Net income grew 18.1% year-over-year to $25.1 million.
Operating margins expanded to 9.4% from 9.0%.
Repaid $30 million of revolving credit facility debt.
Potential Medicaid spending reductions under the OBBBA legislation.
The Q1 2026 filing presents a company in transition, balancing impressive cash flow generation against systemic regulatory risks. On one hand, the operational metrics—specifically the compression of days sales outstanding to 36 days and the surge in net income—point to a highly efficient management team. The successful divestiture of New York operations and the acquisition of HomeCourt Home Care in Indiana show a disciplined approach to geographic optimization. However, the overarching narrative is one of dependency. Addus is tethered to the budgetary whims of the Illinois government and the federal CMS payment schedules. While the shift toward managed care offers a path toward diversification, the short-term outlook remains sensitive to variable interest rates and potential Medicaid contractions. Investors are essentially weighing the company's exceptional current cash conversion against the binary risk of state-level reimbursement shifts.